Amylin Receptor Agonism and Metabolic Peptide Therapeutics Driving...

toegevoegd een audio Wellness

2026-10-29 07:04:52 - Translate -

Amylin Receptor Agonism and Metabolic Peptide Therapeutics Driving Market Expansion

Surging global prevalence of Type 2 diabetes mellitus, expanding clinical focus on combination anti-obesity therapeutics, and accelerating research into amyloid aggregation inhibition are driving strategic interest in the global Islet Amyloid Polypeptide Market. Islet Amyloid Polypeptide (IAPP, or Amylin) is a pancreatic peptide co-secreted with insulin that regulates postprandial glucose...

0 Reacties 0 aandelen 197 Views 0 voorbeeld